Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KLK1 | P06870 | 2/20 | 0.32 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 2/20 | 0.32 |
| ▸ | F11 | P03951 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL29019096 | 0.90 | TP53 (0.33) | LMNAALOX15BLMPMP22NOS1 | |
| Trifluoroacetic Acid SCHEMBL27509737 | 0.90 | LMNA (0.32) | LMNAALOX15BLMPMP22NOS1 | |
| Trifluoroacetic Acid SCHEMBL7764428 | 0.88 | ACHE (0.38) | LMNANOS1NOS2ALDH1A1ACHE | |
| Trifluoroacetic Acid SCHEMBL2409655 | 0.88 | ACHE (0.38) | LMNANOS1NOS2ALDH1A1ACHE | |
| Trifluoroacetic Acid SCHEMBL31438646 | 0.88 | ACHE (0.38) | LMNANOS1NOS2ALDH1A1ACHE | |
| Trifluoroacetic Acid SCHEMBL5744812 | 0.88 | LMNA (0.53) | LMNAALOX15BLMPMP22NOS1 | |
| Trifluoroacetic Acid SCHEMBL7442074 | 0.88 | FFAR3 (0.38) | LMNAALDH1A1TSHRFFAR3LCK | |
| Trifluoroacetic Acid SCHEMBL937102 | 0.88 | LMNA (0.53) | LMNAALOX15BLMPMP22NOS1 | |
| Trifluoroacetic Acid SCHEMBL22557988 | 0.88 | LMNA (0.53) | LMNAALOX15BLMPMP22NOS1 | |
| Trifluoroacetic Acid SCHEMBL29921600 | 0.88 | LMNA (0.53) | LMNAALOX15BLMPMP22NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115915795-A | Perovskite solar cell containing double-layer trifluoroacetate modification layer and preparation method thereof | 河北工业大学 | 2023-04-04 | — | — | CN | claimed |
| CN-115915795-A | Perovskite solar cell containing double-layer trifluoroacetate modification layer and preparation method thereof | 河北工业大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115915795-A | Perovskite solar cell containing double-layer trifluoroacetate modification layer and preparation method thereof | 河北工业大学 | 2023-04-04 | — | — | CN | disclosed |
| EP-1487813-A1 | BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS | Bayer Pharmaceuticals Corporation (US) | 2004-12-22 | — | — | EP | disclosed |
| EP-1282413-A4 | HALOGENATED 2-AMINO-5,6 HEPTENOIC ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | PHARMACIA CORP (US) | 2004-12-01 | — | — | EP | disclosed |
| WO-2003072561-A1 | BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS | BAYER PHARMACEUTICALS CORPORATION (US) | 2003-09-04 | — | — | WO | disclosed |
| EP-1282413-A1 | HALOGENATED 2-AMINO-5,6 HEPTENOIC ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | Pharmacia Corporation (US) | 2003-02-12 | — | — | EP | disclosed |
| US-6465686-B2 | ADMINISTERING HALOGENATED AMIDINO OR OXYAMIDINO COMPOUND TO TREAT DISEASES CAUSED BY NITRIC OXIDE SYNTHASE | PHARMACIA CORPORATION | 2002-10-15 | — | — | US | disclosed |
| US-20020049202-A1 | Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors | GRAPPERHAUS MARGARET L (US) | 2002-04-25 | — | — | US | disclosed |
| WO-2001078719-A1 | HALOGENTATED 2-AMINO-5,6 HEPTENOIC ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | PHARMACIA CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049202-A1 | Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors | ALOX5, PTGIS, ALAD | LMNA 4478/4885ALOX15 5/4885BLM 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.